Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ongoing ALTTO study modified

Sep. 12, 2011

Genentech discloses new brain-penetrant PI3K inhibitors

Sep. 12, 2011

ME-143 enters clinical development

Sep. 9, 2011

Alchemia opens recruitment in phase II HA-irinotecan trial

Sep. 9, 2011

FDA clears DelMar Pharmaceuticals' IND for phase I/II VAL-083 trial

Sep. 9, 2011

Novel recombinant proteins catalyze tRNA aminoacylation

Sep. 9, 2011

Novartis develops novel cyclin-dependent kinase inhibitors

Sep. 9, 2011

Phase I/II data presented on DAC-060 in nonmelanoma skin cancer

Sep. 9, 2011

Safety data presented from clinical evaluation of BIBF-1120 in hepatocellular carcinoma

Sep. 9, 2011

Novartis gains E.U. approval for Votubia

Sep. 8, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...